About The Institute

The idea of establishing the Institute dates back to late 80′s, when the initiative was taken to create in Poland a modern research institute involved in the molecular and cellular research in biomedicine. On the initiative of the Polish Academy of Sciences (PAN) and supported by the State Committee for Scientific Research (KBN), in 1995 an international agreement between the Government of the Republic of Poland and UNESCO was signed establishing the International Institute of Molecular and Cell Biology in Warsaw (IIMCB). The Institute began its independent scientific activity on 1st January 1999. Institute organizational objectives are contained in the Parliamentary Bill of 1997, which provides the legal basis of IIMCB functioning. To be in line with internationally accepted trends several distinctive features of IIMCB should be noted. The principles of organization of the Institute also differ from other research institutes in the country:

  • an important body is the International Advisory Board, acting as the Scientific Council;
  • the leader of each research team  is selected in an international competition;
  • group leader’s initial employment is limited to a five-year contract;

Three years after beginning the research work, progress of research is assessed by the International Advisory Board. Based on IAB’s recommendation professor’s contract may be either terminated or extended. The International Institute of Molecular and Cell Biology is directly subordinate to the President of the Polish Academy of Sciences, who supervises the organization and activities of the Institute. The President of PAN nominates members of IAB and the Institute’s Directors. The Institute is financed in part from the national budget (basic subvention; budgetary subvention via PAN) and in part from other sources (Ministry of Science and Higher Education, Foundation for Polish Science, National Science Center, National Center for Research and Development, Framework Programs of EU, Max Planck Society, Howard Hughes Medical Institute, European Molecular Biology Organisation, National Institutes of Health, Wellcome Trust, European Science Foundation, etc.). About 80% of funds arrive as competitive grant awards received by the group leaders.

IIMCB is an institute offering prospects for the best young researchers. It is a place where they can find laboratories of the same quality level as in other renowned research centers in the world. IIMCB is recognized more and more by international scientific circles. Over 25% of our researchers are employees who come from foreign universities and institutes. Together we build a creative environment where concepts and ideas are implemented. The research carried out in IIMCB  is mainly focused on fundamental biomedical problems. Major topics include the following:

  • chaperones and their role in cancer
  • the molecular basis of neurodegenerative disease (including Alzheimer’s disease)
  • the biology of dendritic tree development under normal and pathological conditions
  • interdependence between intracellular endocytic transport and nuclear signal transduction
  • the crystallographic structural determination of proteins involved in antibiotic resistance
  • the structures and functions of enzymes that act on nucleic acids, their role in DNA repair and degradation, RNA processing and modification
  • the mechanics of the actomyosin cortex